SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-000957
Filing Date
2021-01-04
Accepted
2021-01-04 16:12:51
Documents
3
Period of Report
2020-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d104121d8k.htm 8-K 22533
2 EX-99.1 d104121dex991.htm EX-99.1 14489
3 GRAPHIC g104121g0104200643158.jpg GRAPHIC 2900
  Complete submission text file 0001193125-21-000957.txt   42479
Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 21501915
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences